GC Pharma’s plasma treatment still in demand, even after failing to get approval
May 18, 2021
Local demand for biotech company GC Pharma‘s experimental plasma treatment against the new coronavirus remains even after the company failed to receive conditional use approval here, according to industry sources Tuesday. According to sources, Kyungpook National University Hospital on Friday received an emergency use authorization for the treatment, just three days after the Ministry of Food and Drug Safety rejected GC Pharma‘s application for conditional use. In South Korea, expe